Results 51 to 60 of about 247,522 (263)
FEBS Letters, EarlyView.The process of internalization of the Shiga toxin A subunit via formation of a complex with the Shiga toxin B subunit, which specifically binds to the Gb3 receptor. The peptide is designed to act as a carrier of drugs into cancer cells. Here, we explored the potential of peptides derived from the catalytic A subunit of Shiga toxin (STxA) to be drug ...
Giulia Opassi +6 more
wiley +1 more source
Conserved binding mode but diverse interfaces of MreC‐PBP2 interactions
FEBS Letters, EarlyView.The crystal structure of abMreC reveals a conserved two β‐barrel architecture and provides structural insights into its role within the bacterial elongasome. The abMreC–abPBP2 complex model identifies the molecular basis of MreC‐mediated PBP2 recognition, contributing to the regulation of peptidoglycan synthesis.
Hyunseok Jang +4 more
wiley +1 more source
Pyroelectric Properties of Bismuth Borate BZBO Single Crystals
Crystals, 2021 Pyroelectric properties of orthorhombic Bi2ZnB2O7 (BZBO) crystals were investigated by using the charge integration method. The primary and the secondary pyroelectric coefficients of BZBO crystals were found to be 6.4 and −6.5 µC/(m2·°C), respectively ...
Feifei Chen +3 more
doaj +1 more source
Chemical crystallography and crystal engineering [PDF]
IUCrJ, 2014 Today, there is very little doubt that chemistry owes as much to crystallography as crystallography does to chemistry. This mutual synergy defines modern chemical crystallography.
openaire +4 more sources
Structure‐forward targeting of claudins with synthetic binders
FEBS Letters, EarlyView.Claudins form the paracellular barriers between epithelial and endothelial tissues at tight junctions and are targets for molecular binders with the goal of modulating barrier permeability. Claudin‐binding molecules are relevant in drug delivery or in altering claudin interactions with disease‐causing proteins.
Alex J. Vecchio
wiley +1 more source
Charge densities and crystal engineering [PDF]
Acta Crystallographica Section A Foundations of Crystallography, 2011 This chapter discusses the ways in which the present techniques and tools of charge density analysis can contribute to the burgeoning field of crystal engineering. The principal focus is on use of theoretical and experimental charge densities, Hirshfeld surface analysis, as well as the calculation of energies of intermolecular interactions and their ...
openaire +1 more source
The role of miR‐335‐5p in the redifferentiation of BRAF p.V600E thyroid cancers
Molecular Oncology, EarlyView.The BRAF p.V600E mutation promotes thyroid cancer dedifferentiation and radioiodine resistance. Using a network approach, we identified miR‐335‐5p as a key regulator of BRAF‐mutated thyroid tumors. Restoring miR‐335‐5p increased thyroid‐specific gene expression and iodine uptake in cells and organoids.
Valeria Pecce +11 more
wiley +1 more source
npj Computational Materials, 2022 Electrically controlled half-metallicity in antiferromagnets is of great significance for both fundamental research and practical application. Here, by constructing van der Waals heterostructures composed of two-dimensional (2D) A-type antiferromagnetic ...
Yaping Wang +6 more
doaj +1 more source
Crystal Engineering in Continuous Plug-Flow Crystallizers [PDF]
Crystal Growth & Design, 2017 Size, shape, and polymorphic form are the critical attributes of crystalline particles and represent the major focus of today's crystallization process design. This work demonstrates how crystal properties can be tuned efficiently in solution via a tubular crystallizer that facilitates rapid temperature cycling.
Maximilian O. Besenhard +3 more
openaire +3 more sources
CCDC80 suppresses high‐grade serous ovarian cancer migration via negative regulation of B7‐H3
Molecular Oncology, EarlyView.PAX8 is a lineage‐specific master regulator of transcription in high‐grade serous ovarian cancer (HGSC) progression. We show for the first time that PAX8 facilitates proliferation and metastasis by repressing the cell autonomous tumor suppressor CCDC80 and inducing B7‐H3 expression.
Aya Saleh +12 more
wiley +1 more source